Vaccination Expectations in HNSCC. - Wikidata - awgldk - TriplyDB

Vaccination Expectations in HNSCC.

Vaccination Expectations in HNSCC.

http://www.wikidata.org/entity/Q38971587

about

Vaccination Expectations in HNSCC.

http://www.wikidata.org/entity/Q38971587

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Vaccination Expectations in HNSCC.

@en

type

label

Vaccination Expectations in HNSCC.

@en

prefLabel

Vaccination Expectations in HNSCC.

@en

P1433

Q38971587-281DEF2A-1163-473C-BDF7-160544817F30

P1476

Q38971587-1F571DD6-87CE-4214-9C12-909B05CF7B9D

P2093

Q38971587-B34583C4-CD70-4F0B-A087-E375CCFEC3F9

P2860

Q38971587-02A3488C-0D51-4F18-A41F-C91355331DE9

Q38971587-0389679E-45CB-45B1-A34A-00032EBD86B5

Q38971587-10697B78-CE54-45B7-B74A-F484F17D6A57

Q38971587-145D4E1A-1B3E-4AD2-BE6D-A2962DC57255

Q38971587-1A7D577C-6717-4000-8F1F-B0BF964A8EED

Q38971587-1F7C5493-B328-4622-B657-EAFA0EA9B2B0

Q38971587-23732051-5EBD-400E-9740-F021ECE2998A

Q38971587-2B6CF667-9F0E-43D1-ACBC-BF345CC204DB

Q38971587-2BD496AC-971E-4731-AC83-006E537F2629

Q38971587-2D7A3DFF-5596-4C56-8CA8-655B108D6886

P304

Q38971587-5630C3B0-E762-48F4-A198-89B10537997A

P31

Q38971587-5130DD82-EEF9-4ADF-B685-4646B906A5D2

P356

Q38971587-D129EB4D-8A91-41BB-8A67-10CDF9A2E70C

P478

Q38971587-B2EE7745-DB26-45BE-A9EF-CBF73A42BF31

P50

Q38971587-28EEA467-DAEB-4B73-A49D-25B99E859A6A

P577

Q38971587-CD85BE4A-059E-451C-BFC8-60CC4D445387

P698

Q38971587-7F14AD4E-ED85-4752-9B00-BBC2539ACE4F

P356

978-3-319-43580-0_21

P1433

Recent Results in Cancer Research

P1476

Vaccination Expectations in HNSCC

@en

P2093

Jaana Rautava

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

Prevalence of human papillomavirus 16 in esophageal cancer among the Chinese population: a systematic review and meta-analysis

Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis

HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?

More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population.

Geographic origin is a significant determinant of human papillomavirus prevalence in oesophageal squamous cell carcinoma: systematic review and meta-analysis.

Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study.

Association between human papillomavirus (HPV) and oesophageal squamous cell carcinoma: a meta-analysis.

P304

257-267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-3-319-43580-0_21

http://www.w3.org/2001/XMLSchema#string

P478

206

http://www.w3.org/2001/XMLSchema#string

P50

Stina Syrjänen

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27699546

http://www.w3.org/2001/XMLSchema#string